National Brain Mapping Lab
Tehran, 1439957131, Iran
NCT Number: NCT06030024
The purpose of the current open-lable study was to use low-frequency repetitive transcranial magnetic stimulation (rTMS) to improve the attention deficits in a sample of adult patients suffering from attention deficit disorder. Participants received 10 sessions of rTMS over Fz (located using the EEG 10-20 international system) and underwent assessments of their attentional capacity using the gradCPT task in an fMRI scanner, before and after the intervention. Other behavioral assessments of their attention symptoms have also been conducted.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Tehran, 1439957131, Iran
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Magnetic pulses delivered to the Fz area of the brain in a low frequency (1 Hz) manner.
Time frame: Up to 10 days, i.e., before and after the completion of the 10 sessions of rTMS
Shortened version (4 min) of the continuous go/no-go task: gradual-onset continuous performance task (gradCPT)
Time frame: Baseline, after 5 days of stimulation, after 10 days of stimulation; Range= 0-6; Higher scores represent worse outcome
The 6-item ASRS-V1.1 Adult ADHD Self-Report
Time frame: Baseline, after 5 days of stimulation, after 10 days of stimulation; Range:0 - 54; Higher scores represent worse outcome
Investigator-Rated Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-IV (I-ADHD RS-IV) with adult prompts
University of Tehran
Other
An Open-lable Investigation of the Effect of rTMS on Attention in an Adult Sample Suffering From ADD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05200936
ADHD, Attention Deficit Disorder
Maastricht, Netherlands
View Trial DetailsNCT00919906
ADHD, Asperger Syndrome
Eugene, Oregon, United States
View Trial DetailsNCT06797570
ADD, ADHD
View Trial DetailsNCT06491836
Attention Deficit Disorder, Attention Deficit Disorder with Hyperactivity
Cairo, Abbassia, Egypt
View Trial Details